ArticleGastroenterology report2026

Exploratory biomarker findings from regorafenib plus toripalimab in patients with refractory metastatic colorectal cancer (REGOTORI study).

Yi-Chen Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.